NCT05592080View on ClinicalTrials.gov

Exploring Liver and Muscle Fat Content Using MRI

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

June 1, 2022

Conditions
Polycystic Ovary Syndrome
Interventions
RADIATION

MRI

MRI-mDIXON-Quant examinations, anthropometric measures, body composition, hormonal and biochemical assays were performed in all participants, and the liver fat fraction (LFF) and muscle fat fraction (MFF) represented the fat content in the liver and skeletal muscle, respectively.

Trial Locations (1)

110004

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Bing He

OTHER

NCT05592080 - Exploring Liver and Muscle Fat Content Using MRI | Biotech Hunter | Biotech Hunter